Zusammenfassung
Der episodische Kopfschmerz vom Spannungstyp (eSK) gilt als die häufigste Kopfschmerzform. Tritt der Kopfschmerz vom Spannungstyp an mehr als 15 Tagen im Monat in mindestens 3 aufeinanderfolgenden Monaten auf, spricht man vom chronischen Kopfschmerz vom Spannungstyp (cSK). In den letzten Jahren zeigte sich, dass gerade die Abgrenzung einer eSK-Attacke von einer leichten Migräneattacke und die Abgrenzung eines cSK von einer chronischen Migräne schwierig ist. Im Folgenden sollen Kriterien zur leichteren Abgrenzung sowie die Therapie des Kopfschmerzes vom Spannungstyp diskutiert werden. Im Weiteren werden Befunde vorgestellt, die für oder gegen eine gemeinsame Pathophysiologie (im Sinne der Konvergenzhypothese) von Kopfschmerzen vom Spannungstyp und Migräne sprechen.
Abstract
Episodic tension type headache is considered to be the most prevalent primary headache. If tension type headache occurs on more than 15 days per month for at least 3 consecutive months, it is classified as chronic tension type headache. In recent years, it has become obvious that it is difficult to distinguish between episodic tension type headache and a moderate migraine attack and also between chronic tension type headache and chronic migraine. In the paper, we discuss how the differential diagnosis can be more specific and which therapy is supported by the literature. In addition, we discuss differences and similarities of tension type headache and migraine and a possible similar pathophysiology of both (convergence hypothesis).
Literatur
Allais G, Chiarle G, Sinigaglia S, Mana O, Benedetto C (2019) Migraine during pregnancy and in the puerperium. Neurol Sci 40(Suppl 1):81–91
Andrasik F (2010) Biofeedback in headache: an overview of approaches and evidence. Cleve Clin J Med 77(Suppl 3):72–76
Bendtsen L (2000) Central sensitization in tension-type headache-possible pathophysiological mechanisms. Cephalalgia 20:486–508
Bendtsen L, Jensen R (2004) Mirtazapine is effective in the prophylactic treatment of chronic tension-type headache. Neurology 62(10):1706–1711
Bigal ME, Serrano D, Buse D, Scher A, Stewart WF, Lipton RB (2008) Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache 48:1157–1168
Brennum J, Kjeldsen M, Olesen J (1992) The 5‑HT1-like agonist sumatriptan has a significant effect in chronic tension-type headache. Cephalalgia 12(6):375–379
Breslau N, Schultz LR, Stewart WF, Lipton RB, Lucia VC, Welch KM (2000) Headache and major depression: is the association specific to migraine? Neurology 54(2):308–313
Cady RK (2007) The convergence hypothesis. Headache 47(Suppl 1):44–51
Castien RF, van der Windt DA, Grooten A, Dekker J (2011) Effectiveness of manual therapy for chronic tension-type headache: a pragmatic, randomised, clinical trial. Cephalalgia 31(2):133–143
Chen WT, Chou KH, Lee PL et al (2018) Comparison of gray matter volume between migraine and “strict-criteria” tension-type headache. J Headache Pain 19(1):4. https://doi.org/10.1186/s10194-018-0834-6
Couch JR, Amitriptyline Versus Placebo Study Group (2011) Amitriptyline in the prophylactic treatment of migraine and chronic daily headache. Headache 51(1):33–51
Castien RF, van der Wouden JC, De Hertogh W (2018) Pressure pain thresholds over the cranio-cervical region in headache: a systematic review and meta-analysis. J Headache Pain 19(1):9
Chitsaz A, Ghorbani A, Dashti M, Khosravi M, Kianmehr M (2017) The prevalence of osmophobia in migranous and episodic tension type headaches. Adv Biomed Res 2017(6):44
Diener HC, Bussone G, Van Oene JC, Lahaye M, Schwalen S, Goadsby PJ (2007) Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. TOPMAT-MIG-201(TOP-CHROME) Study Group. Cephalalgia 27(7):814–823
Diener HC, Pfaffenrath V, Pageler L, Peil H, Aicher B (2005) The fixed combination of acetylsalicylic acid, paracetamol and caffeine is more effective than single substances and dual combination for the treatment of headache: a multicentre, randomized, double-blind, single-dose, placebo-controlled parallel group study. Cephalalgia 25(10):776–787
Do TP, Heldarskard GF, Kolding LT, Hvedstrup J, Schytz HW (2018) Myofascial trigger points in migraine and tension-type headache. J Headache Pain 19(1):84
Dodick DW, Turkel CC, DeGryse RE, Aurora SK, Silberstein SD, Lipton RB, Diener HC, Brin MF, PREEMPT Chronic Migraine Study Group (2010) Onabotulinumtoxin A for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache 50(6):921–936
Fernández-de-Las-Peñas C, Fernández-Muñoz JJ, Palacios-Cena M, Parás-Bravo P, Cigarán-Méndez M, Navarro-Pardo E (2018) Sleep disturbances in tension-type headache and migraine. Ther Adv Neurol Disord 11:1–6
Fernández-de-Las-Peñas C, Ge HY, Alonso-Blanco C, González-Iglesias J, Arendt-Nielsen L (2010) Referred pain areas of active myofascial trigger points in head, neck, and shoulder muscles, in chronic tension type headache. J Bodyw Mov Ther 14(4):391–396
Ferrari MD, Roon KI, Lipton RB, Goadsby PJ (2001) Oral triptans (serotonin 5‑HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet 358(9294):1668–1675
Fuller-Thomson E, Hodgins GA (2019) Suicide attempts among those with migraine: findings from a nationally representative Canadian study. Arch Suicide Res 4:1–20
Fumal A, Schoenen J (2008) Tension-type headache: current research and clinical management. Lancet Neurol 7(1):70–83
Gaul C, van Doorn C, Webering N, Dlugaj M, Katsarava Z, Diener HC, Fritsche G (2011) Clinical outcome of a headache-specific multidisciplinary treatment program and adherence to treatment recommendations in a tertiary headache center: an observational study. J Headache Pain 12(4):475–483
Göbel H, Fresenius J, Heinze A, Dworschak M, Soyka D (1996) Effectiveness of Oleum menthae piperitae and paracetamol in therapy of headache of the tension. Nervenarzt 67:672–681
Haag G, Diener HC, May A, Meyer C, Morck H, Straube A, Wessely P, Evers S (2011) Self-medication of migraine and tension-type headache: summary of the evidence-based recommendations of the Deutsche Migräne und Kopfschmerzgesellschaft (DMKG), the Deutsche Gesellschaft für Neurologie (DGN), the Österreichische Kopfschmerzgesellschaft (ÖKSG) and the Schweizerische Kopfwehgesellschaft (SKG). J Headache Pain 12(2):201–217
Hagen K, Stovner LJ, Zwart JA (2020) Time trends of major headache diagnoses and predictive factors. Data from three Nord-Trøndelag health surveys. J Headache Pain 21(1):24
Headache Classification Committee of the International Headache Society (2018) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 38(1):1–211
Holroyd KA, O’Donnell FJ, Stensland M, Lipchik GL, Cordingley GE, Carlson BW (2001) Management of chronic tension-type headache with tricyclic antidepressant medication, stress management therapy and their combination. JAMA 285:2208–2215
Honningsvåg LM, Håberg AK, Hagen K, Kvistad KA, Stovner LJ, Linde M (2018) White matter hyperintensities and headache: a population-based imaging study (HUNT MRI). Cephalalgia 38(13):1927–1939. https://doi.org/10.1177/0333102418764891
Jackson JL, Shimeall W, Sessums L, Dezee KJ, Becher D, Diemer M, Berbano E, O’Malley PG (2010) Tricyclic antidepressants and headaches: systematic review and meta-analysis. BMJ 341:c5222. https://doi.org/10.1136/bmj.c5222
Jackson JL, Mancuso JM, Nickoloff S, Bernstein R, Kay C (2017) Tricyclic and tetracyclic antidepressants for the prevention of frequent episodic or chronic tension-type headache in adults: a systematic review and meta-analysis. J Gen Intern Med 32(12):1351–1358
Jensen R (1999) Pathophysiological mechanisms of tension-type headache: a review of epidemiological and experimental studies. Cephalalgia 19:602–621
Juang KD, Wang SJ, Fuh JL, Lu SR, Su TP (2000) Comorbidity of depressive and anxiety disorders in chronic daily headache and its subtypes. Headache 40:818–823
Kim J, Cho SJ, Kim WJ, Yang KI, Yun CH, Chu MK (2017) Insomnia in tension-type headache: a population-based study. J Headache Pain 18(1):95
Kropp P, Meyer B, Dresler T, Fritsche G, Gaul C, Niederberger U, Förderreuther S, Malzacher V, Jürgens TP, Marziniak M, Straube A (2016) Entspannungsverfahren und verhaltenstherapeutische Interventionen zur Behandlung der Migräne. Leitlinie der DMKG. Nervenheilkunde 35:502–515
Kruit MC, van Buchem MA, Launer LJ, Terwindt GM, Ferrari MD (2010) Migraine is associated with an increased risk of deep white matter lesions, subclinical posterior circulation infarcts and brain iron accumulation: the population-based MRI CAMERA study. Cephalalgia 30(2):129–136. https://doi.org/10.1111/j.1468-2982.2009.01904.x
Láinez MJA, Monzón MJ (2001) Chronic daily headache. Curr Neurol Neurosci Rep 1:118–124
Lampl C, Marecek S, May A, Bendtsen L (2006) A prospective, open-label, long-term study of the efficacy and tolerability of topiramate in the prophylaxis of chronic tension-type headache. Cephalalgia 26(10):1203–1208
Landgraf MN, von Kries R, Heinen F, Langhagen T, Straube A, Albers L (2016) Self-reported neck and shoulder pain in adolescents is associated with episodic and chronic migraine. Cephalalgia 36(8):807–811
Lee MJ, Park BY, Cho S, Kim ST, Park H, Chung CS (2019) Increased connectivity of pain matrix in chronic migraine: a resting-state functional MRI study. J Headache Pain 20(1):29. https://doi.org/10.1186/s10194-019-0986-z
Liang Z, Galea O, Thomas L, Jull G, Treleaven J (2019) Cervical musculoskeletal impairments in migraine and tension type headache: a systematic review and meta-analysis. Musculoskelet Sci Pract 42:67–83
Lieba-Samal D, Wöber C (2011) Sex Hormones and primary headache other than migraine. Curr Pain Headache Rep 15(5):407–414
Linde K, Allais G, Brinkhaus B, Manheimer E, Vickers A, White AR (2009) Acupuncture for tension-type headache. Cochrane Database Syst Rev 21(1):CD7587
Lipton RB, Cady RK, Stewart WF, Wilks K, Hall C (2002) Diagnostic lessons from the spectrum study. Neurology 58(9 Suppl 6):S27–S31
Mathew NT, Reuveni U, Perez F (1987) Transformed or evolutive migraine. Headache 27(2):102–106
Melchart D, Streng A, Hoppe A, Brinkhaus B, Wit C, Wagenpfeil S, Pfaffenrath V, Hammes M, Hummelsberger J, Irnich D, Weidenhamme W, Willich SN, Linde A (2005) Acupuncture in patients with tension-type headache: randomised controlled trial. BMJ 331(7513):376–382
Merikangas KR, Cui L, Richardson AK, Isler H, Khoromi S, Nakamura E, Lamers F, Rössler W, Ajdacic-Gross V, Gamma A, Angst J (2011) Magnitude, impact, and stability of primary headache subtypes: 30 year prospective Swiss cohort study. BMJ 343:d5076
Min YW, Lee JH, Min BH, Lee JH, Kim JJ, Chung CS, Rhee PL (2013) Clinical predictors for migraine in patients presenting with nausea and/or vomiting. J Neurogastroenterol Motil 19(4):516–520
Müller B, Dresler T, Gaul C, Glass Ä, Jürgens TP, Kropp P, Ruscheweyh R, Straube A, Förderreuther S (2019) More attacks and analgesic use in old age: self-reported headache across the lifespan in a German sample. Front Neurol 10:1000
Oguz Akarsu E, Baykan B, Ertas M, Zarifoglu M, Orhan EK, Saip S, Siva A, Karli N, Turkish Headache Study Group (2020) The persistence versus interchangeability of migraine and tension-type headaches in a 5-year population-based validated survey. Cephalalgia 40(1):39–48
Pfaffenrath V, Fendrich K, Vennemann M, Meisinger C, Ladwig KH, Evers S, Straube A, Hoffmann W, Berger K (2009) Regional variations in the prevalence of migraine and tension-type headache applying the new IHS criteria: the German DMKG Headache Study. Cephalalgia 29(1):48–57
Rossi P, Vollono C, Valeriani M, Sandrini G (2011) The contribution of clinical neurophysiology to the comprehension of the tension-type headache mechanisms. Clin Neurophysiol 122(6):1075–1085
Russell MB, Saltyte-Benth J, Levi N (2006) Are infrequent episodic, frequent episodic and chronic tension-type headache inherited? A population-based study of 11 199 twin pairs. J Headache Pain 7(3):119–126. https://doi.org/10.1007/s10194-006-0299-x
Russell MB (2007) Genetics of tension-type headache. J Headache Pain 8(2):71–76. https://doi.org/10.1007/s10194-007-0366-y
Scher AI, Stewart WF, Ricci JA, Lipton RB (2003) Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain 106(1/2):81–89
Schmidt-Wilcke T, Leinisch E, Straube A, Kampfe N, Draganski B, Diener HC, Bogdahn U, May A (2005) Gray matter decrease in patients with chronic tension type headache. Neurology 65(9):1483–1486
Schulte-Mattler WJ, Krack P, BoNTTH Study Group (2004) Treatment of chronic tension-type headache with botulinum toxin A: a randomized, double-blind, placebo-controlled multicenter study. Pain 109(1/2):110–114
Seo JG, Kim KT, Moon HJ, Kuk Do J, Kim SY, Park SP (2019) Suicidality and its risk factors in tension-type headache patients: a multicenter case-control study. J Clin Neurosci 69:21–25
Sjaastad O (2011) Tension-type headache: one or more headaches? Funct Neurol 26:165–170
Stovner LJ, Andree C (2010) Prevalence of headache in Europe: a review for the Eurolight project. J Headache Pain 11(4):289–299
Straube A et al (2015) Therapie des episodischen und chronischen Kopfschmerzes vom Spannungstyp und anderer chronischer täglicher Kopfschmerzen (Herausgegeben von der Kommission Leitlinien der Deutschen Gesellschaft für Neurologie sowie der Deutschen Migräne und Kopfschmerz Gesellschaft März 2015; www.dgn.org; www.dmkg.org; www.awmf.de. Zugegriffen: 25. Juni 2020)
Straube A, Andreou A (2019) Primary headaches during lifespan. J Headache Pain 20(1):35
Straube A (2010) Botulinumtoxin bei Kopfschmerzen: Ende eines langen Weges? Akt Neurol 37:327–332
Torelli P, Jensen R, Olesen J (2004) Physiotherapy for tension-type headache: a controlled study. Cephalalgia 24(1):29–36
Vuralli D, Boran HE, Cengiz B, Coskun O, Bolay H (2017) Somatosensory temporal discrimination remains intact in tension-type headache whereas it is disrupted in migraine attacks. Cephalalgia 37(13):1241–1247
Wallasch TM, Kropp P (2012) Multidisciplinary integrated headache care: a prospective 12-month follow-up observational study. J Headache Pain 13(7):521–529
Wieckiewicz M, Grychowska N, Zietek M, Wieckiewicz G, Smardz J (2017) Evidence to use botulinum toxin injections in tension-type headache management: a systematic review. Toxins (Basel) 9(11):E370. https://doi.org/10.3390/toxins9110370
Yoon MS, Katsarava Z, Obermann M, Fritsche G, Oezyurt M, Kaesewinkel K, Katsarova A, Santowski I, Diener H, Moebus S (2012) Prevalence of primary headaches in Germany: results of the German Headache Consortium Study. J Headache Pain 13(3):215–223
Yu S, Han X (2015) Update of chronic tension-type headache. Curr Pain Headache Rep 19(1):469
Zissis NP, Harmoussi S, Vlaikidis N, Mitsikostas D, Thomaidis T, Georgiadis G, Karageorgiou KA (2007) A randomized, double-blind, placebo-controlled study of venlafaxine XR in out-patients with tension-type headache. Cephalalgia 27(4):315–324
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
A. Straube: Persönliche Honorare für Fortbildungsvorträge und Advisory Boards von Allergan, AllergoSan, Bayer, Novartis, Lilly, Teva. Forschungsförderung durch Deutsche Forschungsgemeinschaft (DFG), Bundesministerium für Bildung und Forschung (BMBF), Universität München, Friedrich-Baur Stiftung. S. Förderreuther: Persönliche Honorare für Fortbildungsvorträge und Advisory Boards von Allergan, AstraZeneca, Novartis, Hormosan Pharma, Sanofi. O.E. Eren: Reiseunterstützung von Allergan, Lilly. Forschungsförderung durch Friedrich-Baur-Stiftung, BMBF.
Für diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.
Rights and permissions
About this article
Cite this article
Straube, A., Förderreuther, S. & Eren, O.E. Kopfschmerz vom Spannungstyp. Schmerz 34, 464–475 (2020). https://doi.org/10.1007/s00482-020-00495-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00482-020-00495-5
Schlüsselwörter
- Episodischer Kopfschmerz vom Spannungstyp
- Chronischer Kopfschmerz vom Spannungstyp
- Migräne
- Chronischer täglicher Kopfschmerz
- Absteigendes schmerzhemmendes System